TNF and neurosarcoidosis: A systematic review and meta‐analysis from 2016 that focused on the clinical features, treatments, and outcomes of neurosarcoidosis patients did not report the proportional rate of positive outcomes in patients receiving TNF‐alpha antagonist therapy.